You need read it again. Stalmer clearly said the partial clinical hold is set for chronic administration. They need new pharmacological evidence for PBT2 as antibiotics as I have told you half a year before. Then they could be entitled to have a discussion with FDA. Hopefully more data will be reported in the coming months.
Antibiotic resistance fund aims 2-4 new antibiotics by 2030, page-8
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
-0.001(11.1%) |
Mkt cap ! $20.98M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.4¢ | $10.55K | 2.255M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 64 | 78009948 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 28507238 | 24 |
View Market Depth
| Last trade - 15.09pm 25/06/2024 (20 minute delay) ? |
| ATH (ASX) Chart |